The short answer
Yes. Every long GLP-1 trial shows the same shape: fast loss in the first months, a gentler slope, then a flattening in the later months as the body settles at a new weight with a lower energy spend. A stall is a flat line with a cause you can name, and that is the one to take to your prescriber.
At GLP-1 SOS, the message that arrives around month five reads the same way every time: stuck for three weeks and afraid it has stopped working. Here is what the trial curves and the body’s own accounting say.
Same scale, different cause
A plateau or a stall
A plateau: expected
- Flat for four weeks or more
- After months of steady loss
- Same dose, no missed shots
- Eating and moving about the same
- Clothes still fitting looser
A stall: find the cause
- A dose step that never happened
- Missed or late shots
- Snacks and drinks crept back
- New medication, short sleep, more alcohol
- Eating past the fullness signal
- Two flat weeks called a plateau
On a slowed gut, water and stool can hide a fat change for two weeks.
What is actually happening
STEP 1 followed adults on Wegovy 2.4 mg for 68 weeks, 16 of them escalation, for an average loss of 14.9 percent. SURMOUNT-1 followed adults on Zepbound 5, 10 or 15 mg for 72 weeks, up to 20 of them escalation, for average losses of 15 to 20.9 percent. In both, the weight curves fall steeply through the first months, slope more gently through the middle, and level off in the final months. Nobody kept losing at the early rate.
Weight is defended, not just carried. The brain treats a range of body weight as its set point and pushes back against loss with hunger and a lower energy spend. A GLP-1 lowers the weight the brain is willing to defend by acting on its appetite circuits; it does not remove the defense. As the gap between where you are and where the body will now sit closes, loss slows.
A smaller body burns fewer calories at rest and with every step, so the meals that produced a deficit in month two produce a smaller one in month eight. Studies of moderate weight loss find that resting energy expenditure falls somewhat more than the lost tissue predicts, an effect called adaptive thermogenesis, though its size varies widely between people. Meanwhile intake creeps: small meals start to feel normal and the extra bites stop registering. The deficit narrows from both sides until it closes; that closing point is the plateau.
Lab note
The scale stops when intake and spend meet. Arithmetic, not failure.
A plateau is flat for weeks at a stable maintenance dose, after months of loss, with eating and movement unchanged. A stall is flat because something changed: a skipped dose step, missed shots, snacks and drinks that came back, a new medication, short sleep, more alcohol, or eating past the fullness signal. On a slowed gut, water, salt and stool can also hide a fat change for two weeks, so a short flat line is often not a plateau at all.
Inside the plateau
What happens when the weight stabilizes
1
Smaller body, smaller burn
Every pound gone is a pound you no longer carry or feed.
2
Resting burn drops a little extra
Adaptive thermogenesis: the body spends less than the lost tissue alone predicts.
3
Appetite quietly recalibrates
Small meals start to feel normal; the extra bites stop registering.
4
The deficit closes
When intake and spend meet, the weight holds. That is the plateau.
What to do
- Give it four weeks before you name it. Weigh once a week, same morning, same conditions. Two flat weeks on a slowed gut is usually water and stool; four flat weeks at a stable dose is a plateau.
- Measure something other than weight. Waist at the navel once a month, and one pair of pants you use as a gauge. Fat can keep leaving while the scale holds.
- Audit the creep for three days. Write down every bite and every drink, including the tastes while cooking and the wine. The appetite effect makes small meals feel like nothing, and the extras add up quietly.
- Put protein first at every meal. Muscle is the part of your resting burn you can keep. Eat the protein before the rest of the plate, and do not let a small appetite turn into a carbohydrate-only day.
- Add movement you were not doing last month. A ten-minute walk after each meal and two short strength sessions a week raise the spend side of the equation, and muscle is what protects the resting burn as weight falls.
- Check sleep and alcohol. Short sleep raises hunger the next day, and alcohol adds calories while loosening the fullness signal. Both are common, quiet causes of a stall.
- Bring a one-page log to your prescriber. Dose, the date of each step, weekly weights, and the three-day audit. Ask whether you are on a maintenance dose or still stepping up, whether there is a step left, and whether this is the weight where you hold. Never change the dose on your own.
When to call your doctor
Call your prescriber the same day if:
- The flat line comes with vomiting you cannot control
- You have severe stomach pain
- You feel faint when you stand
- You have not been able to eat or drink normally for more than a day
- Your weight is rising quickly with swelling in your legs
- Your urine is dark and scarce
- Your mood has dropped in a way that worries you
A flat line is normal. A flat line with new symptoms is not.
From the people behind the Lab
You do not have to figure this out alone.
GLP-1 SOS is the daily companion made for life on a GLP-1. Plain answers like this one, a support team that replies to real questions from real people, and daily formulas like GLP-1 SOS Daily Gut Relief, designed around the side effects that come with the medication. The GLP-1 Lab is our free education arm: no login, no paywall, no hype. Side effects are part of the road. Suffering through them is not.
Questions people also ask
When do you plateau on Ozempic or Wegovy?
There is no fixed week. In STEP 1 the average curve fell steeply through the first months at 2.4 mg, slowed through the middle of the 68 weeks and leveled off toward the end. Where your own curve flattens depends on your starting weight, your dose and how much intake creeps back. Months of loss followed by a flat stretch is the pattern, not a sign of a fault.
How do you break a plateau on a GLP-1?
First confirm it is one: four flat weeks at a stable maintenance dose. Then work the two sides of the deficit. Intake: a three-day audit, protein first, liquid calories and alcohol out. Spend: walk after meals and add two short strength sessions a week. If those change nothing over another month, bring the log to your prescriber and discuss the dose together.
Does increasing the dose fix a plateau?
Sometimes, and only your prescriber can decide. The Wegovy label lists 1.7 mg and 2.4 mg as maintenance doses and allows an increase to 7.2 mg only for adults who have tolerated 2.4 mg for at least four weeks and for whom more weight reduction is clinically indicated. Zepbound’s maintenance doses are 5, 10 and 15 mg. A higher dose also brings the gut reactions back, so the log matters more than the request.
Does a plateau mean the medication has stopped working?
No. The drug level at a stable dose is steady week to week, and the trials kept people at the maintenance dose for a full year while the curve flattened. A plateau is the body arriving at the weight it will now defend, with the medication still holding appetite down. In the Wegovy trial that switched people to placebo after 20 weeks, weight climbed back, which is the opposite of a medication that has stopped.
Sources (6)
- Wegovy (semaglutide) injection, Prescribing Information. Novo Nordisk / FDA, revised June 2026.
- Zepbound (tirzepatide) injection, Prescribing Information. Eli Lilly, revised August 2026.
- Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). New England Journal of Medicine, 2021.
- Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). New England Journal of Medicine, 2022.
- Adaptive thermogenesis after moderate weight loss: magnitude and methodological issues. European Journal of Nutrition, 2021.
- Does adaptive thermogenesis occur after weight loss in adults? A systematic review. British Journal of Nutrition, 2022.
Reviewed by the GLP-1 SOS editorial team · Education, not medical advice · Talk to your prescriber about your dose and your symptoms.
